R.R. Mantri

ORCID: 0000-0003-0310-1299
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Cardiac Arrhythmias and Treatments
  • Cardiac pacing and defibrillation studies
  • Heart Failure Treatment and Management
  • Cardiac Structural Anomalies and Repair
  • Coronary Interventions and Diagnostics
  • Blood Pressure and Hypertension Studies
  • Cardiovascular Function and Risk Factors
  • Pericarditis and Cardiac Tamponade
  • Atrial Fibrillation Management and Outcomes
  • Lipoproteins and Cardiovascular Health
  • Cardiac Valve Diseases and Treatments
  • Congenital Heart Disease Studies
  • Vascular Procedures and Complications
  • Healthcare Systems and Public Health
  • Cardiac, Anesthesia and Surgical Outcomes
  • Cardiac Imaging and Diagnostics
  • Cardiovascular Disease and Adiposity
  • Cardiovascular and Diving-Related Complications
  • Neural Networks and Applications
  • Potassium and Related Disorders
  • Vascular anomalies and interventions
  • Kawasaki Disease and Coronary Complications
  • Cardiac and Coronary Surgery Techniques
  • Cardiovascular Issues in Pregnancy
  • Diabetes Treatment and Management

Sir Ganga Ram Hospital
2014-2025

Sir Ganga Ram Hospital
2021-2023

Bombay Hospital
2023

Kidney Centre
2023

Cipla (India)
2023

Medanta The Medicity
2023

Max Super Speciality Hospital
2023

Mount Sinai Hospital
2005

Icahn School of Medicine at Mount Sinai
2005

Sanjay Gandhi Post Graduate Institute of Medical Sciences
1993-1994

Hypertension is a highly prevalent issue worldwide. The prevalence of underdiagnosed hypertension in India calls for the need this consensus article, which aims to optimize screening strategies. In modified Delphi approach was used develop statements. Key recommendations include adoption standardized protocols across diverse healthcare settings, incorporating both office-based and out-of-office blood pressure measurements (OBPM). By implementing these evidence-based strategies, improve early...

10.59556/japi.73.0926 article EN PubMed 2025-04-01

Abstract Background: Worsening heart failure (WHF) is characterized by the progression of symptoms in patients with established HF, necessitating intensified treatment, typically diuretics. Outpatient (OP) management WHF offers an alternative to hospitalization, as many experience a gradual onset symptoms, allowing timely intervention. However, OP often underrecognized and excluded from clinical trials, highlighting need for structured guidance. This expert consensus aims address this gap...

10.4103/jpcs.jpcs_23_25 article EN cc-by-nc-sa Journal of the Practice of Cardiovascular Sciences 2025-01-01

The prevalence of premature coronary artery disease (CAD) in India is two to three times more than other ethnic groups. Untreated heterozygous familial hypercholesterolemia (FH) one the important causes for CAD. As age advances, these patients without treatment have 100 increased risk cardiovascular (CV) mortality resulting from myocardial infarction (MI). Recent evidence suggests that 250 individuals may be affected by FH (nearly 40 million people globally). It indicated true global...

10.1016/j.ihj.2018.12.004 article EN cc-by-nc-nd Indian Heart Journal 2019-01-03

The PANARrhythMia and Heart Failure Registry (PANARM HF) characterized demographic, clinical interventional therapy indication profiles of cardiac arrhythmia (CA) heart failure (HF) patients in India.Consulting Physicians (CP) who medically manage CA HF enrolled with one or more the following: syncope, pre-syncope, dyspnea, palpitation, fatigue LV dysfunction. CPs were trained by cardiologists (IC) to identify CA/HF indicated for implantable device/radiofrequency ablation (RFA). 59 CP's, 16...

10.1016/j.ihj.2016.11.329 article EN cc-by-nc-nd Indian Heart Journal 2017-01-25

Heart failure (HF) is a global health concern that prevalent in India as well. HF reported at younger age Indian patients with comorbidity of type 2 diabetes (T2DM) approximately 50% patients. Sodium-glucose cotransporter-2 inhibitors (SGLT2i), originally approved for T2DM, are new guideline-recommended and treatment strategies HF. Extensive evidence highlights SGLT2i exhibits profound cardiovascular (CV) benefits beyond glycemic control. SGLT2i, conjunction other guideline-directed medical...

10.59556/japi.71.0440 article EN PubMed 2024-01-01

Chronic kidney disease (CKD) is a major contributor to morbidity and mortality in India. CKD often coexists with heart failure (HF), diabetes, hypertension. All these comorbidities are risk factors for renal impairment. HF pathophysiologically intertwined, the deterioration of one can worsen prognosis other. There need safe pharmacological therapies that target both also useful hypertension diabetes. Neurohormonal activation achieved through sympathetic nervous system (SNS),...

10.59556/japi.72.0543 article EN PubMed 2024-05-01

The incidence of heart failure (HF) in India is estimated to be 0.5-1.7 cases per 1,000 people year, and approximately 4,92,000-1.8 million new are detected every year. Despite the high rate mortality associated with HF, most patients do not receive maximal guideline-directed medical therapy (GDMT). Current guidelines advocate early multidrug combination four classes drugs, namely, beta-blockers (BBs), mineralocorticoid receptor antagonists (MRAs), angiotensin receptor-neprilysin inhibitors...

10.59556/japi.72.0664 article EN PubMed 2024-09-01

10.1016/0167-5273(94)90039-6 article EN International Journal of Cardiology 1994-09-01

Coronary artery aneurysm after stent implantation is a rare complication, the reported incidence being 0.3%–6% and most are pseudoaneurysms. Extraluminal migration of previously implanted drug eluting several months deployment extremely rare. We report two unusual cases extraluminal deployed in right coronary due to pseudoaneurysm.

10.1016/j.ihjccr.2020.11.001 article EN cc-by-nc-nd IHJ Cardiovascular Case Reports (CVCR) 2020-09-01

Passive fixation of coronary sinus leads is an imperfect technique with a high incidence intraoperative and post-operative dislocations. The retained guide wire has been proposed for stabilizing the left ventricular lead. Long term effects on lead parameters are unknown. We describe two cases in which was because recurrent Both patients at 9-12 months followup showed marked rise impedance loss capture. Fluoroscopy revealed multiple sites fragmentation. causes degradation should be removed.

10.21767/2471-8157.100066 article EN cc-by Interventional Cardiology Journal 2017-01-01

During cardiac resynchronization therapy implantation, left ventricular lead placement involves transvenous of leads via the coronary sinus and into a tributary branch. At present, most widely used method for (LV) LV Lead dislodgement is common cause reoperation. We describe case where stent was placed to stabilize against vessel wall.

10.18621/eurj.397159 article EN The European Research Journal 2018-06-17
Coming Soon ...